APA (7th ed.) Citation

R, S., SR, O., K, N., S, K., JA, D., M, M., . . . CU, N. (2020). Changes in primary and secondary hemostasis in patients with CLL treated with venetoclax and ibrutinib. Leukemia & lymphoma, 61(14), 3422. https://doi.org/10.1080/10428194.2020.1811270

Chicago Style (17th ed.) Citation

R, Svanberg, et al. "Changes in Primary and Secondary Hemostasis in Patients with CLL Treated with Venetoclax and Ibrutinib." Leukemia & Lymphoma 61, no. 14 (2020): 3422. https://doi.org/10.1080/10428194.2020.1811270.

MLA (9th ed.) Citation

R, Svanberg, et al. "Changes in Primary and Secondary Hemostasis in Patients with CLL Treated with Venetoclax and Ibrutinib." Leukemia & Lymphoma, vol. 61, no. 14, 2020, p. 3422, https://doi.org/10.1080/10428194.2020.1811270.